In silico drug design and molecular docking of novel amidophosphonates and sulfamidophosphonates as inhibitors of urokinase-type plasminogen activator
Seif‐Eddine Djouad, Malika Berredjem, Fatima Zohra Hadjadj Aoul, Fouzia Bouchareb, Meriem Guerfi, Taïbi Ben Hadda, Mohamed Aissaoui, Billel Belhani
Topics & Concepts
ChemistryIn silicoBioavailabilityDrugPharmacologyPlasminogen activatorPharmacophoreDocking (animal)Lipinski's rule of fiveUrokinaseComputational biologyBiochemistryMedicineInternal medicineBiologyGeneNursingComputational Drug Discovery MethodsSynthesis and biological activityEnzyme function and inhibition